If you want a broader overview of why site rotation matters, our guide to where to inject GLP-1 breaks down the basics
Heat can increase solubility for many peptides, but avoid high temperatures which might cause protein denaturation or chemical changes
But one question continues to come up for patients considering treatment: "What happens after I stop taking GLP-1 medication?" "What happens after I stop taking GLP-1 medication?" It's a valid concern

We discuss: Medicare Bridge Program eligibility requirements Zepbound, Wegovy, Foundayo (orforglipron), and GLP-1 coverage updates BMI and comorbidity qualifications Prediabetes, sleep apnea, cardiovascular disease, and obesity treatment access How Medicare patients can obtain GLP-1 medications Why obesity is finally being treated as a chronic disease The future of obesity medicine and Medicare coverage Concerns about access to care vs access to medication Muscle loss, nutrition, strength training, and healthy weight loss The Treat and Reduce Obesity Act (TROA) This may be one of the most important developments in obesity treatment history, potentially opening the door for millions of Americans living with obesity, prediabetes, cardiovascular disease, and other weight-related conditions to receive evidence-based care